Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Fischer, Thomas

Class:IdPerson:9660402
_displayNameFischer, Thomas
_timestamp2019-09-09 19:47:39
created[InstanceEdit:9660400] Rothfels, Karen, 2019-09-09
firstnameThomas
initialT
surnameFischer
(author)[LiteratureReference:9660401] Identification of a novel RalGDS-related protein as a candidate effector for Ras and Rap1
[LiteratureReference:9691821] Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptor
[LiteratureReference:9695656] Leukemogenic potency of the novel FLT3-N676K mutant
[LiteratureReference:9699239] Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain
[LiteratureReference:9703523] AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations
[LiteratureReference:9703529] Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation
[Change default viewing format]
No pathways have been reviewed or authored by Fischer, Thomas (9660402)